Robert Riestenberg, a third-year medical student, was the first author of a recent study that evaluated statin use among people with HIV, a population at an increased risk for cardiovascular disease.
Northwestern scientists specializing in HIV and AIDS gathered to share their experiences during a panel held December 3, to commemorate World AIDS Day.
A behavioral program significantly reduced the sexual risk for HIV infection among young transgender women, according to a Northwestern Medicine clinical trial.
The National Institutes of Health has awarded an $8.8 million grant to Keep It Up!, a novel online HIV prevention program that has been shown to reduce sexually transmitted infections in gay young men by 40 percent.
Feinberg scientists are confronting significant, global challenges — from antimicrobial resistance to HIV — through collaborative, cutting-edge basic science and clinical research within the Division of Infectious Diseases.
Drugs commonly used to prevent HIV transmission from mother to child during pregnancy were not associated with a higher risk of adverse birth outcomes, according to a new study.
Immunosuppression among patients with HIV was associated with a significantly higher likelihood of heart arrhythmias, according to a new study.
Northwestern Medicine scientists showed how enzyme inhibitors might be used to halt a molecular process that can cause neurodegeneration in patients with HIV.
A Northwestern Medicine study found the human immunodeficiency virus uses proteins called diaphanous-related formins to hijack the cytoskeleton of healthy cells.
Northwestern Medicine scientists have developed a novel method of tracking HIV infection, allowing the behavior of individual virions to be connected to infectivity.